XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2014 $ 14 $ 113,476     $ (72,336) $ 41,154
Balance (in shares) at Dec. 31, 2014 14,036,985   29,231      
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation expense   2,108       2,108
Exercise of stock options   373       373
Exercise of stock options (in shares) 327,098          
Issuance of common stock in connection with secondary public offering ($3.75 per share and $6.00 per share for the years ended 2017 and 2015), net of expenses of $2,555 and $2,200 for the years ended 2017 and 2015 $ 5 28,131       28,136
Issuance of common stock in connection with secondary public offering (in shares) 5,056,003          
Net loss         (24,850) (24,850)
Balance at Dec. 31, 2015 $ 19 144,088     (97,186) 46,921
Balance (in shares) at Dec. 31, 2015 19,420,086   29,231      
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation expense   3,077       3,077
Exercise of stock options $ 1 123       124
Exercise of stock options (in shares) 118,365          
Issuance of Restricted Stock (in shares) 195,900          
Net loss         (28,643) (28,643)
Balance at Dec. 31, 2016 $ 20 147,288     (125,829) 21,479
Balance (in shares) at Dec. 31, 2016 19,734,351   29,231      
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation expense   2,880       2,880
Issuance of common stock under equity distribution agreement, net of expenses of $380 $ 10 14,843       14,853
Issuance of common stock under equity distribution agreement (in shares) 9,768,142          
Exercise of stock options $ 1 95       96
Exercise of stock options (in shares) 90,509          
Issuance of common stock in connection with secondary public offering ($3.75 per share and $6.00 per share for the years ended 2017 and 2015), net of expenses of $2,555 and $2,200 for the years ended 2017 and 2015 $ 10 37,684       37,694
Issuance of common stock in connection with secondary public offering (in shares) 10,733,334          
Issuance of Restricted Stock (in shares) 223,600          
Net loss         (18,898) (18,898)
Unrealized loss on investments       $ (96)   (96)
Balance at Dec. 31, 2017 $ 41 $ 202,790   $ (96) $ (144,727) $ 58,008
Balance (in shares) at Dec. 31, 2017 40,549,936   29,231